Introduction
Dendritic cells (DC) are the most potent antigen-presenting cells and play a pivotal role in modulating immune responses. 1 DC have the potential to induce immune rejection or tolerance and thus play a critical role in transplantation. 2, 3 Plasmacytoid precursor DC facilitate hematopoietic stem cell (HSC) engraftment in an allogeneic setting without causing graft-versus-host diseases (GVHD). 4 Generation of regulatory DC by treatment of DC with IL-10 induces tolerance across MHC barriers in both human xenogeneic GVHD and murine GVHD models. 5 These results suggest the possibility for potential therapeutic uses of modified DC to achieve transplantation tolerance.
Little is known about potential roles for DC in proliferation, survival and differentiation of hematopoietic stem/progenitor cells. Murine bone marrow-derived DC support colony formation of bone marrow CFU-GM and CFU-megakaryocytes in vitro. 6 Whether human DC, especially tolerogenic DC, support hematopoiesis has not been reported. A population of DC that induces tolerance as well as enhancing hematopoietic recovery may be of therapeutic use. In transplantation settings, host conditioning and GVHD lead to systemic and local inflammation that could possibly induce maturation of DC.
Maturation signals such as bacterial lipopolysaccharide (LPS) induce DC to upregulate messenger RNA for cytokines and chemokines, 7 which might modulate systematic immune reactions and hematopoietic recovery after transplantation. 7 We reported that M-CSF and IL-4 induce differentiation of CB monocytes into a population of IL-10 high IL-12 absent DC (M-DC) with tolerogenic potential. 8 
This is different 3
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modulates DC differentiation and function, [9] [10] [11] but whether TGF-β1 modulates M-DC immune function and plays a potential supporting role for these cells in hematopoiesis was not known. Maturation of DC is associated with activation of at least 3 members of the mitogen-activated protein kinase (MAPK) family, including extracellular signalregulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 kinase. [12] [13] [14] MAPK activation associated with maturation plays an important role in regulation of phenotype, cytokine production and T cell regulatory function of human DC. [12] [13] [14] In the present study,
we evaluated effects of TGF-β1 in modulating M-DC immune function, enhancing cytokine-induced ex-vivo expansion of myeloid progenitor cells, and a role for MAPK in these effects. Cells were analyzed by flow cytometry.
Production of conditioned medium (CM).
Cultured M-DC and GM-DC were harvested on day 5 and washed three times to remove residual cytokines. Cells (5 × 10 5 /ml) were stimulated with 1 μg/ml LPS for 24 h in RPMI 1640 culture medium. Supernatant was collected and frozen at -80°C. Control CM prepared with 1μg/ml LPS without cells was used as a control for the effects of LPS itself. Control medium are RPMI 1640 culture medium.
Ex vivo expansion.
For colony assessment of pre-cultured freshly isolated CB, CD34 + cells were plated in triplicate as described 15, 16 in 0.9% methylcellulose culture medium with 30% FBS and a combination of recombinant human GM-CSF (10 ng/ml), interleukin-3 (IL-3, 10 ng/ml), stem cell factor (SCF, 50 ng/ml) and erythropoietin (Epo, 1 U/ml). Different CD34 + cell concentrations were plated in order to find the μM Hepes, 50 μM β-mercaptoethanol, 100 U/ml penicillin and 100 μg/ml streptomycin) and 25-50% v/v CM in the presence or absence of a combination of previously determined optimal progenitor cell expanding growth factors (50 ng/mL SCF, 100 ng/mL Flt-3 ligand (FL), and 100 ng/mL Thrombopoietin (TPO): =SFT). In some experiments, neutralizing goat anti-M-CSF or goat control Ab (20 μg/ml) (R&D systems) was added into cultures containing CM and SFT. Cells were cultured for 1 week, harvested and counted to determine absolute cell numbers after expansion, stained with CD34-PE to determine percentage of CD34 + cells, and plated at various concentrations in 0.9% methylcellulose culture medium as described above to determine generation of myeloid progenitor cells. Cells were plated in low (5 %) oxygen for ex vivo expansion and for colony assessment. Colonies were scored after 12-14 days in methycellulose culture.
Absolute numbers of myeloid progenitor cells were calculated after 1 week culture.
Assay for cytokine protein levels. Cells were washed extensively and 2.5 × 10 5 cells/ml were stimulated with LPS (1 μg/ml) in culture medium in 24-well plates for 24 h.
Washed cells were also incubated with ERK inhibitor U0126 for 30 min before addition of LPS. Conditioned media were sent toWhatman (Sanford, ME) for analysis of multiple cytokines using microspot ELISA technology. Each sample was analyzed in triplicate. Statistical analysis. A two-tailed paired student t test (unless otherwise indicated) was used to determine statistical significance. Values of P <0.05 were considered significant.
Primary and secondary mixed leukocyte reaction (MLR

Results
Effects of TGF-β1 on CB and AB M-CSF/IL-4-induced M-DC differentiation.
We previously reported that CB monocytes cultured with M-CSF and IL-4 (M-DC) differentiated into a tolerogenic population of cells, but with a heterogeneous morphology. 8 In this report, we analyzed effects of TGF-β1 on M-DC differentiation.
Addition of TGF-β1 to highly purified CB monocytes cultured with M-CSF and IL-4 Cytokine levels in mature TGF-M-DC CM were quantified using microSpot ELISA technology and mature M-DC CM was analyzed as a control. Results of the cytokine analysis are summarized in Table 1 . Interestingly, a number of the cytokines analyzed In contrast, TGF-M-DC and M-DC generated from AB were not consistently less stimulatory than adult GM-DC in terms of expression level of CD25 and Foxp3 ( Figure   4C , right 2 panels). TGF-M-DC derived from 3 out of 6 AB donors we tested were capable of inducing marked levels of CD25 and Foxp3 expression on CB CD4 + T cells at a comparable level to GM-DC (data not shown). were more anti-inflammatory than GM-DC. We now tested whether in the presence of TGF-β, such differences between M-and GM-CSF-induced DC still exist. Results in Figure 5 show that TGF-M-DC displayed reduced capability in induction of allogeneic MLR compared with TGF-GM-DC. The LPS induced TGF-M-DC secreted greater amounts of immune suppressive cytokines IL-10, but lower amounts of inflammatory cytokines (IL-1, IL-6, GM-CSF and VEGF) than mature TGF-GM-DC (Table 1B) . This suggests that M-CSF-induced DC might generally be more favorable than GM-CSFinduced DC for silencing the immune system, regardless of whether or not these DC populations are produced in the presence of TGF-β.
LPS-activated
To begin to understand the potential intracellular molecules that might underlie (Table 2 ). In contrast, this ERK inhibitor suppressed TGF-β, IL-6
and IL-1-β, and increased GM-CSF by TGF-GM-DC from the same donors. These results suggest that the ERK inhibitor differently regulates cytokine production by TGF-M-DC and TGF-GM-DC. Thus, within the MAPK pathway, at least enhanced ERK signaling in TGF-M-DC might be involved in quantitative cytokine differences we observed between mature populations of TGF-M-DC and TGF-GM-DC.
Discussion
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SDF-1α 750±543 325±192
TGFβ
13±8 5±3
TPO
ND 7687±6556
PDGF-BB 200±78 374±87
IL-2 7±1 7±1
M-CSF ND 2±2
IL-3 ND ND
IL-12 ND ND
IL-17 ND ND
Conditioned medium prepared from 5x10 5 cells/ml. Data represent average cytokine levels of triplicate ± SEM from 4 different donors. * and ** indicates p<0.05 when using one-tailed or two-tailed t test; ND, non-detectable in all 4 donor samples. Table 1B 
M-CSF 13±13 34±34
PDGF-BB 242±101 151±151
IL-2 12±1 22±13
IL-3 ND ND
IL-12 40±40 ND
IL-17 ND ND
Conditioned medium prepared from 2.5x10 5 cells/ml. These samples were from experiments different from those reported in Table 1A , and cells were conditioned in different types of wells in this from those reported in Table 1A . Data represent average cytokine levels of triplicate ± SEM from 2 donors. * and ** indicates p<0.05 when using one (*) or two-tailed (**) paired t-test. ND, non-detectable in all samples. Cytokine levels were detected on protein array slides in triplicate for each sample treated ± ERK inhibitor U0126. Data represent average cytokine levels from triplicate samples ± SEM from 2 donors. * and ** indicates p<0.05 when using one (*) or twotailed (**) paired t-test. and 30 min with LPS. Cell lysate was subjected to western blotting using rabbit polyclonal antibodies specific for p-ERK, -JNK or -P38. PVDF membranes were stripped and reprobed with a rabbit polyclonal antibody specific for total ERK as a loading control.
-TGF-β1
+ TGF-β1 
